Home › Compare › MYSL vs JNJ

MYSL vs JNJ: Dividend Comparison 2026

MYSL yields 25000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MYSL wins by $481652020747103174656.00M in total portfolio value
10 years
MYSL
MYSL
● Live price
25000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$481652020747103174656.00M
Annual income
$477,891,679,681,809,340,000,000,000.00
Full MYSL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MYSL vs JNJ

📍 MYSL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMYSLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MYSL + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MYSL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYSL
Annual income on $10K today (after 15% tax)
$2,125,000.00/yr
After 10yr DRIP, annual income (after tax)
$406,207,927,729,537,960,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MYSL beats the other by $406,207,927,729,537,960,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYSL + JNJ for your $10,000?

MYSL: 50%JNJ: 50%
100% JNJ50/50100% MYSL
Portfolio after 10yr
$240826010373551587328.00M
Annual income
$238,945,839,840,904,670,000,000,000.00/yr
Blended yield
99.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MYSL
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYSL buys
0
JNJ buys
0
No recent congressional trades found for MYSL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMYSLJNJ
Forward yield25000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$481652020747103174656.00M ✓$20.0K
Annual income after 10y$477,891,679,681,809,340,000,000,000.00 ✓$827.78
Total dividends collected$481404327977371041792.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MYSL vs JNJ ($10,000, DRIP)

YearMYSL PortfolioMYSL Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$2,510,700$2,500,000.00$10,676$355.77+$2.50M → MYSL
2$589,298,599$586,612,149.53$11,407$389.39+$589.29M → MYSL
3$129,309,604,119$128,679,054,618.90$12,198$426.53+$129309.59M → MYSL
4$26,527,150,102,459$26,388,788,826,051.22$13,056$467.62+$26527150.09M → MYSL
5$5,087,743,001,217,608$5,059,358,950,607,977.00$13,987$513.12+$5087743001.20M → MYSL
6$912,316,496,169,531,500$906,872,611,158,228,600.00$14,998$563.56+$912316496169.52M → MYSL
7$152,954,929,371,424,950,000$151,978,750,720,523,570,000.00$16,098$619.52+$152954929371424.94M → MYSL
8$23,976,822,470,935,107,000,000$23,813,160,696,507,682,000,000.00$17,295$681.69+$23976822470935108.00M → MYSL
9$3,514,337,444,199,857,700,000,000$3,488,682,244,155,957,000,000,000.00$18,599$750.82+$3514337444199857664.00M → MYSL
10$481,652,020,747,103,200,000,000,000$477,891,679,681,809,340,000,000,000.00$20,022$827.78+$481652020747103174656.00M → MYSL

MYSL vs JNJ: Complete Analysis 2026

MYSL — Stock

MyScreen Mobile, Inc. provides a tool for the mobile advertising market that brings permission and incentive marketing to cellular phone subscribers. It offers MyScreen Mobile that puts the mobile phone users in control of their advertising exposure and pays them for each ad viewed. The company's MyScreen Mobile enables subscribers to get paid for advertisements that appear on their phone. MyScreen Mobile, Inc. was formerly known as Nouveau International, Inc. and changed its name to MyScreen Mobile, Inc. in April 2007. My Screen Mobile, Inc. was incorporated in 1996 and is based in Toronto, Canada.

Full MYSL Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MYSL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYSL vs SCHDMYSL vs JEPIMYSL vs OMYSL vs KOMYSL vs MAINMYSL vs ABBVMYSL vs MRKMYSL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.